Pharmx Technologies Ltd
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more
Pharmx Technologies Ltd (PHX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.552x
Based on the latest financial reports, Pharmx Technologies Ltd (PHX) has a cash flow conversion efficiency ratio of -0.552x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.91 Million) by net assets (AU$16.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharmx Technologies Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Pharmx Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharmx Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmx Technologies Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Garanti Yatirim Ortakligi AS
IS:GRNYO
|
0.026x |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
-0.004x |
|
Innovative Technology Development Corp
VN:ITD
|
N/A |
|
Pierre & Vacances
LSE:0OQ0
|
-0.722x |
|
FORCS Co.Ltd
KQ:189690
|
0.034x |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
0.000x |
|
WVS Financial Corp
OTCQX:WVFC
|
0.019x |
|
Baikowski SASU
PA:ALBKK
|
0.089x |
Annual Cash Flow Conversion Efficiency for Pharmx Technologies Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Pharmx Technologies Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$15.97 Million | AU$3.21 Million | 0.201x | -59.28% |
| 2023-06-30 | AU$22.21 Million | AU$10.94 Million | 0.493x | +421.33% |
| 2022-06-30 | AU$23.20 Million | AU$2.19 Million | 0.095x | -31.46% |
| 2021-06-30 | AU$22.93 Million | AU$3.16 Million | 0.138x | +393.18% |
| 2020-06-30 | AU$13.20 Million | AU$369.00K | 0.028x | -79.21% |
| 2019-06-30 | AU$10.02 Million | AU$1.35 Million | 0.135x | +476.38% |
| 2018-06-30 | AU$14.23 Million | AU$332.00K | 0.023x | +30.98% |
| 2017-06-30 | AU$13.98 Million | AU$249.00K | 0.018x | +127.93% |
| 2016-06-30 | AU$19.91 Million | AU$-1.27 Million | -0.064x | -135.99% |
| 2015-06-30 | AU$19.93 Million | AU$3.53 Million | 0.177x | -41.07% |
| 2014-06-30 | AU$18.87 Million | AU$5.68 Million | 0.301x | -25.59% |
| 2013-06-30 | AU$16.36 Million | AU$6.61 Million | 0.404x | -7.53% |
| 2012-06-30 | AU$10.68 Million | AU$4.67 Million | 0.437x | -44.72% |
| 2011-06-30 | AU$4.65 Million | AU$3.67 Million | 0.791x | +1.31% |
| 2010-06-30 | AU$2.90 Million | AU$2.26 Million | 0.780x | -10.54% |
| 2008-06-30 | AU$5.11 Million | AU$4.46 Million | 0.872x | +148.45% |
| 2007-06-30 | AU$7.55 Million | AU$2.65 Million | 0.351x | -- |